| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.38 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |